C

Clovis Oncology Inc
XETRA:C6O

Watchlist Manager
Clovis Oncology Inc
XETRA:C6O
Watchlist
Price: 8.7 EUR -10.66% Market Closed
Market Cap: €3B

Wall Street
Price Targets

C6O Price Targets Summary
Clovis Oncology Inc

There are no price targets for C6O.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Clovis Oncology Inc Competitors:
Price Targets
CYBR
Cyberark Software Ltd
14% Upside
IBEX
Ibex Ltd
8% Upside
CSGP
CoStar Group Inc
27% Upside
AVDL
Avadel Pharmaceuticals PLC
0% Downside
VAC
Pierre et Vacances SA
25% Upside
MRVL
Marvell Technology Group Ltd
47% Upside

Revenue
Forecast

N/A
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

The compound annual growth rate of Clovis Oncology Inc's revenue for the next 2 years is -4%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Clovis Oncology Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is C6O's stock price target?
Not Available

C6O doesn't have any price targets made by Wall Street professionals.

What is Clovis Oncology Inc's Revenue forecast?
Projected CAGR
-4%

The compound annual growth rate of Clovis Oncology Inc's revenue for the next 2 years is -4%.

Back to Top